Why a common allergy nasal spray might prevent COVID
UC expert shares how it could work
A common over-the-counter nasal spray grabbed headlines and social media buzz recently as a simple, surprising way to reduce your chances of getting COVID-19. Experts say the research behind the headlines is promising but early. The key may be that azelatine spray, used to treat seasonal allergies, helps keep the nose lining calm.
As WebMD reported, the study was published in JAMA Internal Medicine and showed that healthy adults younger than 65 who used the spray three times daily for eight weeks had a 67% reduced risk of testing positive for COVID, compared to people who used a placebo spray. They also had a reduced risk of being diagnosed with the common cold. This latest study builds on nearly a dozen others pointing to azelastine's multi-factor potential to prevent COVID.
Azelastine is FDA-approved for rhinitis, inflamed nasal passages that usually come with a runny or stuffy nose. Anyone with rhinitis who takes azelastine might be "less susceptible to super infections, like COVID or other viruses, because it does have multiple mechanistic effects," said allergist Jonathan A. Bernstein, MD, an expert on azelastine and an adjunct professor at the University of Cincinnati College of Medicine. (He was not involved in the study.)
Research suggests that azelastine may calm a type of protein in the nose that sometimes triggers nasal hyperreactivity, said Bernstein, who has studied the protein, called TRPV1. When the protein is overactive, it can trigger inflammation and damage the nasal lining, making it easier for viruses to slip through. By preventing the protein from becoming overactive, azelastine helps keep the lining intact and less inflamed, making it harder for viruses to penetrate and infect underlying cells, Bernstein said.
For those interested in trying the spray, talk to a doctor first — and don't rely on the spray alone to protect you against COVID, especially if you are 65 or older, have a weakened immune system or have a medical condition that puts you at a higher risk of a severe infection. Experts said the spray should not take the place of good hygiene practices and COVID-19 vaccines.
Read why scientists are focused on the nose when it comes to COVID prevention.
Featured image at top: Illustration of Covid-19 protein/Provided.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.